These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7921442)

  • 1. Nasal polyp inflammation. Effect of topical nasal steroid.
    Kanai N; Denburg J; Jordana M; Dolovich J
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of intranasal budesonide on the infiltration and activation of eosinophils in nasal polyps].
    Zhang L; Han D; Zhang Y; Zhou B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):129-32. PubMed ID: 12768671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids.
    Kim YK; Uno M; Hamilos DL; Beck L; Bochner B; Schleimer R; Denburg JA
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):388-97. PubMed ID: 10030836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.
    de Borja Callejas F; Martínez-Antón A; Picado C; Alobid I; Pujols L; Valero A; Roca-Ferrer J; Mullol J
    Laryngoscope; 2015 May; 125(5):E158-67. PubMed ID: 25641502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cells in nasal mucosa and nasal polyps.
    Morinaka S; Nakamura H
    Auris Nasus Larynx; 2000 Jan; 27(1):59-64. PubMed ID: 10648070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps.
    Hyo S; Kawata R; Kadoyama K; Eguchi N; Kubota T; Takenaka H; Urade Y
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):693-700. PubMed ID: 17638783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of intranasal glucosteroid on the gene expression of interleukin-5 in nasal polyps].
    Zhang L; Han DM; Zhou B; Fan EZ; Liu ZY
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Nov; 39(11):672-5. PubMed ID: 15835818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
    Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
    J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
    Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
    Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
    Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
    Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps.
    Ebbens FA; Maldonado M; de Groot EJ; Alobid I; van Drunen CM; Picado C; Fokkens WJ; Mullol J
    Allergy; 2009 Jan; 64(1):96-103. PubMed ID: 19132974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation.
    Mastruzzo C; Greco LR; Nakano K; Nakano A; Palermo F; Pistorio MP; Salinaro ET; Jordana M; Dolovich J; Crimi DN; Vancheri C
    J Allergy Clin Immunol; 2003 Jul; 112(1):37-44. PubMed ID: 12847477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors influencing the eosinophil infiltration of nasal polyps.
    Jankowski R; Bouchoua F; Coffinet L; Vignaud JM
    Rhinology; 2002 Dec; 40(4):173-8. PubMed ID: 12526243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient.
    Ogata Y; Okinaka Y; Takahashi M
    Rhinology; 1999 Mar; 37(1):16-20. PubMed ID: 10229976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical corticosteroids and nasal reactivity.
    Wihl JA
    Eur J Respir Dis Suppl; 1982; 122():205-10. PubMed ID: 6958486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and significance of interleukin-17 and the infiltrating eosinophils in nasal polyps and nasal mucous of allergic rhinitis].
    Ba L; Du J; Liu Y; Shang T; Yang F; Bian P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jan; 24(2):53-6. PubMed ID: 20306850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of topical corticosteroid on basic fibroblast growth factor in nasal polyp tissue.
    Yariktas M; Doner F; Sutcu R; Demirci M; Dogru H; Yasan H
    Am J Rhinol; 2005; 19(3):248-50. PubMed ID: 16011129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of corticosteroid on eosinophils and expression of transforming growth factor beta 1 in nasal polyps].
    Tao Z; Kong Y; Xiao B; Ye L; Wu X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Aug; 17(8):474-5. PubMed ID: 14577262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
    Tingsgaard PK; Bock T; Larsen PL; Tos M
    Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps.
    Iino Y; Miyazawa T; Kakizaki K; Saigusa H; Katano H; Shiga J; Kanegasaki S
    Acta Otolaryngol; 2006 Jan; 126(1):43-50. PubMed ID: 16308254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.